However, genetic MIF/CD74 deficiency or blocking MIF activity can ameliorate glomerular injury and partially reverse established crescentic glomerulonephritis (Yang et al., 1998; Djudjaj et al., 2016). This evidence concerns the gene MIF and crescentic glomerulonephritis.